Mihir Shah
Affiliations: | 2009-2011 | Department of Pharmacology and Pharmaceutical Sciences | University of Southern California, Los Angeles, CA, United States |
Google:
"Mihir Shah"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Klinngam W, Janga SR, Lee C, et al. (2019) Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome. Scientific Reports. 9: 9559 |
| Shah M, Cabrera-Ghayouri S, Christie LA, et al. (2019) Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development. Pharmaceutical Research. 36: 58 |
| Guo H, Lee C, Shah M, et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Janga SR, Shah M, Ju Y, et al. (2018) Longitudinal Analysis of Tear Cathepsin S Activity Levels in Male Non-Obese Diabetic Mice Suggests its Potential as an Early Stage Biomarker of Sjögren's Syndrome. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 1-35 |
| Hawley D, Tang X, Zyrianova T, et al. (2018) Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjögren's syndrome animal models. Scientific Reports. 8: 9919 |
| Shah M, Edman MC, Reddy Janga S, et al. (2017) Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome. Investigative Ophthalmology & Visual Science. 58: 372-385 |
| Hamm-Alvarez SF, Janga SR, Edman MC, et al. (2014) Tear cathepsin S as a candidate biomarker for Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). 66: 1872-81 |
| Shah M, Edman MC, Janga SR, et al. (2013) A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 269-79 |
| Shi P, Aluri S, Lin YA, et al. (2013) Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 330-8 |
| Shah M, Hsueh PY, Sun G, et al. (2012) Biodegradation of elastin-like polypeptide nanoparticles. Protein Science : a Publication of the Protein Society. 21: 743-50 |